A Parliamentary committee has said the government should earmark a separate fund for the promotion and growth of biologics.
"The committee are given to understand that a lot of deliberation has been made for the promotion and growth of research and development in biologics, but still no headway has been made in the country," the Standing Committee on Chemicals and Fertilisers said in its report tabled in Parliament today.
In India where people are badly affected by diabetes and cancer patients are increasing day by day with no much effective treatment, the biologics is need of the hour, the report added.
The committee chaired by Anandrao Adsul in its recommendation said: "As such the government should earmark a separate fund for promotion and growth of biologics."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app